Sri Vasavi Pharmaceuticals Private Limited
Founded in 1997 and headquartered in Tamil Nadu, India.
1997 | Vellore, Tamil Nadu (India) | Active
Sri Vasavi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Sri Vasavi Pharmaceuticals
Sri Vasavi Pharmaceuticals Private Limited (SVPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 May 1997 and has a history of 27 years and nine months. Its registered office is in Vellore, Tamil Nadu, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrasekaran and Govindasamy Baskaran serve as directors at the Company.
Company Details
- Location
Vellore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN1997PTC038144
- Company No.
038144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 1997
- Date of AGM
08 May 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Trading
Who are the key members and board of directors at Sri Vasavi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindasamy Baskaran  | Managing Director | 08-May-1997 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrasekaran | Director | 08-May-1997 | Current |
Financial Performance of Sri Vasavi Pharmaceuticals.
Sri Vasavi Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sri Vasavi Pharmaceuticals?
In 2017, Sri Vasavi Pharmaceuticals had a promoter holding of 54.55% and a public holding of 45.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sripuram Devi Chits Private Limited
Chandrasekaran is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Vasavi Pharmaceuticals?
Unlock and access historical data on people associated with Sri Vasavi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Vasavi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Vasavi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
